Victory Capital Management Inc Ironwood Pharmaceuticals Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 218,009 shares of IRWD stock, worth $769,571. This represents 0.0% of its overall portfolio holdings.

Number of Shares

218,009

Previous 222,573 2.05%

Holding current value

$769,571

Previous $1.45 Million 38.25%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$3.93 - $7.04 $17,936 - $32,130	-4,564 Reduced 2.05%	218,009 $896,000
Q2 2024 Aug 05, 2024	BUY	$5.58 - $8.61 $529,441 - $816,934	94,882 Added 74.31%	222,573 $1.45 Million
Q1 2024 May 03, 2024	SELL	$8.32 - $15.45 $34.1 Million - $63.3 Million	-4,096,892 Reduced 96.98%	127,691 $1.11 Million
Q4 2023 Feb 05, 2024	SELL	$8.79 - $11.51 $1.6 Million - $2.1 Million	-182,149 Reduced 4.13%	4,224,583 $48.3 Million
Q3 2023 Nov 06, 2023	BUY	$8.25 - $11.35 $5.52 Million - $7.59 Million	668,694 Added 17.89%	4,406,732 $42.4 Million
Q2 2023 Jul 27, 2023	BUY	$10.1 - $11.6 $7.15 Million - $8.21 Million	707,706 Added 23.35%	3,738,038 $39.8 Million
Q1 2023 May 02, 2023	BUY	$10.37 - $12.56 $1.32 Million - $1.6 Million	127,656 Added 4.4%	3,030,332 $31.9 Million
Q4 2022 Feb 10, 2023	BUY	$9.9 - $12.43 $142,074 - $178,382	14,351 Added 0.5%	2,902,676 $36 Million
Q4 2022 Feb 09, 2023	SELL	$9.9 - $12.43 $133,709 - $167,879	-13,506 Reduced 0.47%	2,888,325 $35.8 Million
Q3 2022 Nov 02, 2022	BUY	$10.14 - $12.38 $27.8 Million - $33.9 Million	2,738,889 Added 1680.9%	2,901,831 $30.1 Million
Q2 2022 Aug 01, 2022	SELL	$11.05 - $12.72 $133,108 - $153,225	-12,046 Reduced 6.88%	162,942 $1.88 Million
Q1 2022 May 04, 2022	BUY	$10.61 - $12.88 $180,550 - $219,178	17,017 Added 10.77%	174,988 $2.1 Million
Q4 2021 Feb 07, 2022	BUY	$10.86 - $13.95 $880,572 - $1.13 Million	81,084 Added 105.46%	157,971 $1.84 Million
Q3 2021 Nov 02, 2021	BUY	$11.92 - $13.92 $302,505 - $353,261	25,378 Added 49.27%	76,887 $1 Million
Q2 2021 Aug 03, 2021	BUY	$10.16 - $13.11 $29,270 - $37,769	2,881 Added 5.92%	51,509 $663,000
Q1 2021 May 04, 2021	BUY	$9.04 - $11.86 $59,889 - $78,572	6,625 Added 15.77%	48,628 $544,000
Q4 2020 Feb 01, 2021	BUY	$9.05 - $12.2 $84,146 - $113,435	9,298 Added 28.43%	42,003 $478,000
Q3 2020 Nov 09, 2020	BUY	$8.99 - $10.74 $113,336 - $135,399	12,607 Added 62.73%	32,705 $294,000
Q2 2020 Aug 07, 2020	SELL	$9.14 - $11.97 $1,663 - $2,178	-182 Reduced 0.9%	20,098 $207,000
Q1 2020 May 04, 2020	SELL	$8.58 - $14.01 $49,866 - $81,426	-5,812 Reduced 22.28%	20,280 $205,000
Q4 2019 Feb 06, 2020	BUY	$8.22 - $14.0 $45,456 - $77,420	5,530 Added 26.89%	26,092 $347,000
Q4 2019 Feb 04, 2020	SELL	$8.22 - $14.0 $8,335 - $14,196	-1,014 Reduced 4.7%	20,562 $248,000
Q3 2019 Nov 12, 2019	BUY	$8.59 - $10.96 $185,337 - $236,472	21,576 New	21,576 $185,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Ironwood Pharmaceuticals Inc Transaction History